Literature DB >> 27300020

Expression of developing neural transcription factors in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).

Antonio García Escudero1, Enrique Rodríguez Zarco1, Juan Carlos Girón Arjona2, María José Ríos Moreno3, Katherine Gallardo Rodríguez1, Ana Vallejo Benítez1, Ricardo González Cámpora1.   

Abstract

DIPNECH is characterized by neuroendocrine cell hyperplasia, tumorlets, and eventually carcinoid tumors. Although it is regarded by some authors as a preneoplastic condition, this issue is controversial. New pathologic criteria have recently been proposed for the diagnosis of DIPNECH, and a subgroup of carcinoid tumors expressing developing neural transcription factors (DNTFs), with clinicopathologic features similar to those of DIPNECH, has been recognized. This paper reports on the clinical and pathological findings in three cases of DIPNECH and investigates the expression of three DNTFs (TTF1, ASCL1, and POU3F2). All patients were female, with a mean age of 63 years, and all lesions were located in the periphery of the lung. In two cases, typical carcinoids were associated with a spindle-cell component. All neuroendocrine proliferations were DNTF positive. The morphologic (spindle-cell component), phenotypic (DNTF expression), and clinicopathologic (peripheral tumors, female predominance) similarities suggest that DIPNECH may be a preneoplastic lesion for peripheral carcinoids.

Entities:  

Keywords:  DIPNECH; Developing neural transcription factors; Lung neuroendocrine tumors; Pathology; Preneoplastic lesion

Mesh:

Substances:

Year:  2016        PMID: 27300020     DOI: 10.1007/s00428-016-1962-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  21 in total

1.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity.

Authors:  Alexander Gorshtein; David J Gross; Dganit Barak; Yulia Strenov; Yael Refaeli; Ilan Shimon; Simona Grozinsky-Glasberg
Journal:  Cancer       Date:  2011-07-12       Impact factor: 6.860

Review 2.  Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence.

Authors:  Eric Wirtschafter; Ann E Walts; Sandy T Liu; Alberto M Marchevsky
Journal:  Lung       Date:  2015-06-24       Impact factor: 2.584

3.  Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer.

Authors:  T Yazawa; H Kamma; M Fujiwara; M Matsui; H Horiguchi; H Satoh; M Fujimoto; K Yokoyama; T Ogata
Journal:  J Pathol       Date:  1999-01       Impact factor: 7.996

4.  Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids.

Authors:  Nathalie Sturm; Giulio Rossi; Sylvie Lantuejoul; Mauro Papotti; Sophie Frachon; Christine Claraz; Pierre-Yves Brichon; Christian Brambilla; Elisabeth Brambilla
Journal:  Hum Pathol       Date:  2002-02       Impact factor: 3.466

5.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease.

Authors:  Susan J Davies; John R Gosney; David M Hansell; Athol U Wells; Roland M du Bois; Margaret M Burke; Mary N Sheppard; Andrew G Nicholson
Journal:  Thorax       Date:  2006-11-10       Impact factor: 9.139

6.  TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location.

Authors:  Emma Z Du; P Goldstraw; Jo Zacharias; Olivier Tiffet; Paul J Craig; Andrew G Nicholson; Noel Weidner; Eunhee S Yi
Journal:  Hum Pathol       Date:  2004-07       Impact factor: 3.466

7.  Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors.

Authors:  A L Folpe; A M Gown; L W Lamps; R Garcia; D H Dail; R J Zarbo; R A Schmidt
Journal:  Mod Pathol       Date:  1999-01       Impact factor: 7.842

8.  The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH?

Authors:  Alberto M Marchevsky; Eric Wirtschafter; Ann E Walts
Journal:  Hum Pathol       Date:  2014-11-12       Impact factor: 3.466

9.  Class III/IV POU transcription factors expressed in small cell lung cancer cells are involved in proneural/neuroendocrine differentiation.

Authors:  Jun Ishii; Hanako Sato; Takuya Yazawa; Yukiko Shishido-Hara; Chie Hiramatsu; Yukio Nakatani; Hiroshi Kamma
Journal:  Pathol Int       Date:  2014-09       Impact factor: 2.534

10.  The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain.

Authors:  D Lazzaro; M Price; M de Felice; R Di Lauro
Journal:  Development       Date:  1991-12       Impact factor: 6.868

View more
  2 in total

Review 1.  Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis-Prognostic and Predictive Factors.

Authors:  José Manuel Cameselle-Teijeiro; José Antonio Mato Mato; Ovidio Fernández Calvo; Jesús García Mata
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

Review 2.  Insights into Novel Prognostic and Possible Predictive Biomarkers of Lung Neuroendocrine Tumors.

Authors:  Dimitrios Moris; Ioannis Ntanasis-Stathopoulos; Diamantis I Tsilimigras; Mohamad A Adam; Chi-Fu Jeffrey Yang; David Harpole; Stamatios Theocharis
Journal:  Cancer Genomics Proteomics       Date:  2018 Mar-Apr       Impact factor: 4.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.